TORONTO and EDMONTON, Alberta, March 12, 2024 Aeterna Zentaris Inc. and Ceapro Inc. are pleased to announce that securityholders of both biopharmaceutical development companies approved the.
Aeterna Zentaris Inc. ("Aeterna") and Ceapro Inc. ("Ceapro") are pleased to announce that securityholders of both biopharmaceutical development companies approved the all-stock merger of equals transaction (the "Transaction") at their respective.